| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1022411909 |
| P356 | DOI | 10.1007/S00109-004-0579-3 |
| P8608 | Fatcat ID | release_4pcq5gn6pna6li5v5gi52dpf4m |
| P698 | PubMed publication ID | 15322702 |
| P50 | author | Dirk J van Veldhuisen | Q82060328 |
| Wiek H van Gilst | Q42159122 | ||
| Frans Boomsma | Q45026209 | ||
| P2093 | author name string | Saraswati Pokharel | |
| Yigal M Pinto | |||
| Rudolf A de Boer | |||
| Albert J H Suurmeijer | |||
| Derk A van Kampen | |||
| Frans Boomsma | |||
| Markus Flesch | |||
| P2860 | cites work | Differential regulation of mitogen-activated protein kinases in the failing human heart in response to mechanical unloading | Q77129991 |
| Influence of age on neurohormonal activation and prognosis in patients with chronic heart failure | Q77147303 | ||
| "Stress-responsive" mitogen-activated protein kinases (c-Jun N-terminal kinases and p38 mitogen-activated protein kinases) in the myocardium | Q77167575 | ||
| Role of AT1 and AT2 receptors in regulation of MAPKs and MKP-1 by ANG II in adult cardiac myocytes | Q77181476 | ||
| Early captopril treatment inhibits DNA synthesis in endothelial cells and normalization of maximal coronary flow in infarcted rat hearts | Q77755953 | ||
| The Smad pathway | Q22253316 | ||
| Measurement of protein using bicinchoninic acid | Q26778491 | ||
| Specific role of the extracellular signal-regulated kinase pathway in angiotensin II-induced cardiac hypertrophy in vitro | Q28344062 | ||
| Redox regulation of MAPK pathways and cardiac hypertrophy in adult rat cardiac myocyte | Q32055216 | ||
| Effect of N-acetyl-seryl-aspartyl-lysyl-proline on DNA and collagen synthesis in rat cardiac fibroblasts. | Q32184250 | ||
| Role of Ras and Mapks in TGFbeta signaling | Q33857574 | ||
| Signalling via stress-activated mitogen-activated protein kinases in the cardiovascular system | Q33870078 | ||
| The MEK1-ERK1/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice | Q40388321 | ||
| N-acetyl-Ser-Asp-Lys-Pro inhibits phosphorylation of Smad2 in cardiac fibroblasts. | Q40713598 | ||
| Cross-talk between the p42/p44 MAP kinase and Smad pathways in transforming growth factor beta 1-induced furin gene transactivation | Q40793124 | ||
| Physiological characterization of the hypertensive transgenic rat TGR(mREN2)27. | Q41078608 | ||
| Regulation of angiotensin II-stimulated osteopontin expression in cardiac microvascular endothelial cells: role of p42/44 mitogen-activated protein kinase and reactive oxygen species | Q42505155 | ||
| Hypertensive end-organ damage and premature mortality are p38 mitogen-activated protein kinase-dependent in a rat model of cardiac hypertrophy and dysfunction | Q42509981 | ||
| ERK and p38 MAPK, but not NF-kappaB, are critically involved in reactive oxygen species-mediated induction of IL-6 by angiotensin II in cardiac fibroblasts | Q42511347 | ||
| Involvement of MAP kinase cascades in Smad7 transcriptional regulation | Q42513106 | ||
| Angiotensin II via activation of type 1 receptor upregulates expression of endoglin in human coronary artery endothelial cells | Q43801296 | ||
| Effects of angiotensin-converting enzyme inhibition on the development of the atrial fibrillation substrate in dogs with ventricular tachypacing-induced congestive heart failure | Q43803594 | ||
| Angiotensin II-induced cardiac hypertrophy and hypertension are attenuated by epidermal growth factor receptor antisense. | Q44108423 | ||
| AT1A-mediated activation of kidney JNK1 and SMAD2 in obstructive uropathy: preservation of kidney tissue mass using candesartan | Q44883049 | ||
| Differential role of MAP kinases in stimulation of hepatocyte growth by EGF and G-protein-coupled receptor agonists | Q45713470 | ||
| Induction of mitogen-activated protein kinase signal transduction pathway during gastric ulcer healing in rats | Q46495069 | ||
| Angiotensin II type 1 receptor-induced extracellular signal-regulated protein kinase activation is mediated by Ca2+/calmodulin-dependent transactivation of epidermal growth factor receptor | Q47904445 | ||
| Differential Activation of Signal Transduction Pathways in Human Hearts With Hypertrophy Versus Advanced Heart Failure | Q57396530 | ||
| Reduction in Left Ventricular Messenger RNA for Transforming Growth Factor β 1 Attenuates Left Ventricular Fibrosis and Improves Survival Without Lowering Blood Pressure in the Hypertensive TGR(mRen2)27 Rat | Q57570924 | ||
| Angiotensin II receptor antagonist TCV-116 induces regression of hypertensive left ventricular hypertrophy in vivo and inhibits the intracellular signaling pathway of stretch-mediated cardiomyocyte hypertrophy in vitro | Q72415178 | ||
| Stage-specific differential activation of mitogen-activated protein kinases in hypertrophied and failing rat hearts | Q73683776 | ||
| Angiotensin II activates collagen I gene through a mechanism involving the MAP/ER kinase pathway | Q74316935 | ||
| Angiotensin II-induced cardiac hypertrophy is associated with different mitogen-activated protein kinase activation in normotensive and hypertensive mice | Q74335673 | ||
| P433 | issue | 10 | |
| P921 | main subject | heart failure | Q181754 |
| homozygosity | Q114049690 | ||
| P304 | page(s) | 678-687 | |
| P577 | publication date | 2004-08-20 | |
| P1433 | published in | Journal of Molecular Medicine | Q6295593 |
| P1476 | title | Extracellular signal regulated kinase and SMAD signaling both mediate the angiotensin II driven progression towards overt heart failure in homozygous TGR(mRen2)27. | |
| P478 | volume | 82 |
| Q42159077 | AKIP1, a cardiac hypertrophy induced protein that stimulates cardiomyocyte growth via the Akt pathway |
| Q37930478 | Animal models of cardiorenal syndrome: a review. |
| Q34559487 | Atrial fibrillation induces myocardial fibrosis through angiotensin II type 1 receptor-specific Arkadia-mediated downregulation of Smad7. |
| Q36373654 | Atrial tachyarrhythmia in Rgs5-null mice |
| Q46533413 | Cardiac remodeling during and after renin-angiotensin system stimulation in Cyp1a1-Ren2 transgenic rats |
| Q54545304 | DHRS7c, a novel cardiomyocyte-expressed gene that is down-regulated by adrenergic stimulation and in heart failure. |
| Q36805458 | Effect of renin inhibition and AT1R blockade on myocardial remodeling in the transgenic Ren2 rat |
| Q35132702 | Exendin-4 protects against post-myocardial infarction remodelling via specific actions on inflammation and the extracellular matrix |
| Q37738648 | Galectin-3 in cardiac remodeling and heart failure |
| Q56982274 | Harbingers of hypertrophy and heart failure |
| Q34663709 | Heart failure-associated anemia: bone marrow dysfunction and response to erythropoietin |
| Q51531441 | Hypertrophy induced KIF5B controls mitochondrial localization and function in neonatal rat cardiomyocytes. |
| Q38498280 | Identification of hypertrophy- and heart failure-associated genes by combining in vitro and in vivo models. |
| Q38028652 | In vivo models of cardiac diseases: application to drug development and screening |
| Q54588252 | Induction of kidney injury molecule-1 in homozygous Ren2 rats is attenuated by blockade of the renin-angiotensin system or p38 MAP kinase. |
| Q43269848 | Inhibition of extracellular signal-regulated kinase 1 by adenovirus mediated small interfering RNA attenuates hepatic fibrosis in rats |
| Q27342649 | Klotho and phosphate are modulators of pathologic uremic cardiac remodeling |
| Q36978251 | LOXL4 is induced by transforming growth factor β1 through Smad and JunB/Fra2 and contributes to vascular matrix remodeling. |
| Q51373277 | Metformin improves cardiac function in a nondiabetic rat model of post-MI heart failure. |
| Q37794503 | Molecular mechanisms that control interstitial fibrosis in the pressure-overloaded heart |
| Q28569684 | Oral administration of an angiotensin-converting enzyme 2 activator ameliorates diabetes-induced cardiac dysfunction |
| Q64914593 | Radiological assessment of effectiveness of soluble RAGE in attenuating Angiotensin II-induced LVH mouse model using in vivo 9.4T MRI. |
| Q42914633 | Regulation of the (pro)renin-renin receptor in cardiac remodelling |
| Q33643393 | Rodent heart failure models do not reflect the human circulating microRNA signature in heart failure |
| Q36773152 | Rodent models of heart failure |
| Q37310627 | Role of renin in heart failure and therapeutic potential of direct renin inhibition |
| Q44325888 | Suicidal erythrocyte death, eryptosis, as a novel mechanism in heart failure-associated anaemia |
| Q41593391 | Transforming growth factor β: A potential biomarker and therapeutic target of ventricular remodeling |
| Q28580391 | Transgenic overexpression of the adenine nucleotide translocase 1 protects cardiomyocytes against TGFβ1-induced apoptosis by stabilization of the mitochondrial permeability transition pore |
| Q24625500 | Transient receptor potential (TRP) channels and cardiac fibrosis |
| Q54643074 | Urotensin-2 promotes collagen synthesis via ERK1/2-dependent and ERK1/2-independent TGF-β1 in neonatal cardiac fibroblasts. |
Search more.